Angolan isolation ward empty as Marburg cases mount

Tag: 上海龙凤交流群

first_img A specially equipped isolation ward at Uige province’s 400-bed hospital is empty, even though Marburg cases and deaths are occurring in the area, the WHO reported. “It is apparent that, for the time being, the community does not accept the concept of isolation,” the agency said. “Residents are unwilling to report suspected cases and allow these people to be managed under conditions that reduce the risk of further transmission.” Yesterday the WHO said travelers to Angola should be aware of the Marburg outbreak and avoid close contact with sick people. People who have existing medical conditions and might require hospitalization should consider postponing travel to Angola, and especially to Uige, officials said. To make matters worse, four Red Cross volunteers who had just been trained to educate local residents about the disease were killed by lightning today while on their way to work, the WHO statement said. The agency had announced just yesterday that the International Federation of Red Cross and Red Crescent Societies had decided to send more volunteers to Uige to help fight the epidemic by running educational campaigns. In the past the federation has helped control large outbreaks of Ebola fever, a disease much like Marburg fever. See also: Apr 14 WHO statementhttp://www.who.int/csr/don/2005_04_14a/en/ But Dr. Mike Ryan of the WHO said that even if the drug seems to work in monkeys, it could be months before it could be tried in human patients, according to the story. Travelers leaving Angola should seek medical attention if they experience any illness with fever within 10 days after their departure, the agency said. Further, “WHO recommends that travelers with a clear exposure history be treated as contacts and placed under surveillance for 21 days, during which time their temperature should be monitored daily.” Apr 13 WHO statementhttp://www.who.int/csr/don/2005_04_13/en/ Officials said they were not aware of any Marburg cases in foreign nationals other than those involved in caring for patients in Uige. In other developments, US Army scientists are investigating whether a drug that has shown promise against Ebola fever might work against Marburg, the Associated Press reported yesterday. The report said the drug cured Ebola in a third of a group of monkeys that were treated with it in 2003. Apr 14, 2005 (CIDRAP News) – As the death toll in Angola’s Marburg hemorrhagic fever epidemic reached 215, the World Health Organization (WHO) reported today that Angolans are refusing to report suspected cases and allow patients to be treated in isolation. Because of the resistance to control measures, the agency said, “Family members and other caregivers who refuse to allow patients to be cared for in the isolation facility are being informed of ways to protect themselves from infection and given appropriate supplies. WHO has placed urgent orders for disinfectants, which are currently in short supply in Angola.” In reporting the Red Cross workers’ deaths, the WHO said it “recognizes the importance of this support and deeply regrets the death of these volunteers.” The WHO said the outbreak amounted to 235 cases, including 215 deaths, as of Apr 12, up from 231 cases and 210 deaths the day before. Uige remained the center of the outbreak, with 208 cases and 194 deaths.last_img read more


Tag: 上海龙凤交流群

first_img “We have been developing herbal-based products and mostly use red ginger extract as the main ingredient. And it is such a coincidence that red ginger is in high demand at the moment,” Vidjongtius told a press briefing on Wednesday.Red ginger is a plant that can be easily found in Indonesia. People believe it can help prevent the spread of the coronavirus as it can strengthen the body’s immune system. People also use it as a remedy for a cough or headache. Kalbe Farma already sold a liquid herbal product made from red ginger long before the coronavirus outbreak.Vidjongtius said that at the moment Kalbe Farma had between 400 and 500 tons of red ginger in its warehouses, enough to meet the surge in demand. The red ginger was obtained from about 9,000 farmers across Indonesia who had joined the farmer communities established by Kalbe, he said. The stocks, he said, were enough not only for Kalbe Farma, but also for other producers. Vidjongtius said Kalbe Farma‘s stocks for most of its pharmaceutical products were large enough to meet the demand for the next several months. Demand for red ginger supplements has increased sharply lately, amid growing fears about the spread of the novel coronavirus in the country, as people believe the plant can boost the immune system, a senior executive of a pharmaceutical company has said.Publicly listed Kalbe Farma has increased production of the herbal supplement made from red ginger extract by about 50 percent to meet the increase in demand for such supplements, the company’s president director Vidjongtius said.Read also: Panic hoarding of herbs, medicinal plants amid virus scare takes toll on ‘jamu’ vendors Topics :center_img “We have enough stocks for pharmaceutical products to last 10 to 11 months. The stocks comprise raw materials, half-made products and even stock in outlets,”  he said.Vidjongtius admitted that he initially worried that the COVID-19 outbreak would disrupt the supply of raw materials, as China is the main source of Kalbe Farma’s raw materials. In early February, producers of raw materials in China temporarily closed their production, but he said the disruption did not affect his company because of the large raw material stocks in its warehouses.”We are now less worried, since according to the latest update they [suppliers in China] have started to resume their production, although not at full capacity. They also started to resume the [raw material] shipments, so we are less worried now,” he said.However, although the shipment of raw materials from China would soon return to normal, Kalbe Farma is seeking other sources of raw materials to reduce its dependence on China such as India, Europe and the US.Indonesia’s pharmaceutical industry still greatly relies on imported raw materials. According to the national pharmaceutical industry‘s estimate, about 95 percent of its raw materials are imported, with a total value of US$2.5 billion a year. About 60 percent of the imported raw materials are shipped from China.last_img read more